Literature DB >> 22281695

The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.

Mohammed H Abdulla1, Munavvar A Sattar, Nor A Abdullah, Edward J Johns.   

Abstract

The aim of this study is to assess the effects of losartan and carvedilol on metabolic parameters and renal haemodynamic responses to angiotensin II (Ang II) and adrenergic agonists in the model of fructose-fed rat. Thirty-six Sprague-Dawley rats were fed for 8 weeks either 20% fructose solution (F) or tap water (C) ad libitum. F or C group received either losartan or carvedilol (10 mg/kg p.o.) daily for the last 3 weeks of the study (FL and L) and (FCV and CV), respectively, then in acute studies the renal vasoconstrictor actions of Ang II, noradrenaline (NA), phenylephrine (PE) and methoxamine (ME) were determined. Data, mean±SEM were analysed using ANOVA with significance at P <0.05. Losartan and carvedilol decreased the area under the glucose tolerance curve of the fructose-fed group. The responses (%) to NA, PE, ME and Ang II in F were lower (P <0.05) than C (F vs. C, 17±2 vs. 38±3; 24±2 vs. 48±2; 12±2 vs. 34±2; 17±2 vs. 26±2), respectively. L had higher (P <0.05) responses to NA and PE while CV had blunted (P <0.05) responses to NA, PE and Ang II compared to C (L, CV vs. C, 47±3, 9±2 vs. 38±3; 61±3, 29±3 vs. 48±2; 16±3, 4±3 vs. 26±2), respectively. FL but not FCV group had enhanced (P <0.05) responses to NA, PE and ME compared to F (FL vs. F, 33±3 vs. 17±2; 45±3 vs. 24±2; 26±3 vs. 12±2), respectively. Losartan and carvedilol had an important ameliorating effect on fructose-induced insulin resistance. Losartan treatment could be an effective tool to restore normal vascular reactivity in the renal circulation of the fructose-fed rat.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281695     DOI: 10.1007/s13105-012-0147-1

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  61 in total

1.  Evidence for the role of α1A-adrenoceptor subtype in the control of renal haemodynamics in fructose-fed Sprague-Dawley rat.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Edward J Johns; Nor A Abdullah; Md Abdul Hye Khan
Journal:  Eur J Nutr       Date:  2011-03-04       Impact factor: 5.614

2.  Effect of losartan on vascular function in fructose-fed rats: the role of perivascular adipose tissue.

Authors:  Fengyang Huang; Miguel Angel Rosas Lezama; José Alfredo Pérez Ontiveros; Guadalupe Bravo; Santiago Villafaña; Blanca Estela del-Rio-Navarro; Enrique Hong
Journal:  Clin Exp Hypertens       Date:  2010-01       Impact factor: 1.749

3.  Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats.

Authors:  M Gellai; R DeWolf; R R Ruffolo
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

4.  The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.

Authors:  M H Abdulla; M A Sattar; N A Abdullah; M A H Khan; K R L Anand Swarup; E J Johns
Journal:  Auton Autacoid Pharmacol       Date:  2010-12-20

5.  Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide.

Authors:  Armin Just; Andrea J M Olson; Christina L Whitten; William J Arendshorst
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-01       Impact factor: 4.733

6.  After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.

Authors:  Okcan Basat; Sema Ucak; Selcuk Seber; Erkan Oztekin; Yuksel Altuntas
Journal:  Clin Res Cardiol       Date:  2006-02-06       Impact factor: 5.460

7.  ANG II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats.

Authors:  L Xu; V L Brooks
Journal:  Am J Physiol       Date:  1996-12

8.  Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.

Authors:  S N Iyer; M J Katovich
Journal:  Am J Hypertens       Date:  1996-07       Impact factor: 2.689

9.  Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Authors:  Y Miao; D Dobre; H J Lambers Heerspink; B M Brenner; M E Cooper; H-H Parving; S Shahinfar; D Grobbee; D de Zeeuw
Journal:  Diabetologia       Date:  2010-09-30       Impact factor: 10.122

10.  Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.

Authors:  Leszek Kalinowski; Lawrence W Dobrucki; Miroslawa Szczepanska-Konkel; Maciej Jankowski; Ludmila Martyniec; Stefan Angielski; Tadeusz Malinski
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

View more
  3 in total

1.  Metabolic syndrome and selenium during gestation and lactation.

Authors:  Fátima Nogales; M Luisa Ojeda; Paulina Muñoz Del Valle; Alejandra Serrano; M Luisa Murillo; Olimpia Carreras Sánchez
Journal:  Eur J Nutr       Date:  2015-12-17       Impact factor: 5.614

2.  Fructose: a key factor in the development of metabolic syndrome and hypertension.

Authors:  Zeid Khitan; Dong Hyun Kim
Journal:  J Nutr Metab       Date:  2013-05-25

3.  Cystathione gamma lyase/Hydrogen Sulphide Pathway Up Regulation Enhances the Responsiveness of α1A and α1B-Adrenoreceptors in the Kidney of Rats with Left Ventricular Hypertrophy.

Authors:  Ashfaq Ahmad; Munavvar A Sattar; Maleeha Azam; Mohammed H Abdulla; Safia A Khan; Fayyaz Hashmi; Nor A Abdullah; Edward J Johns
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.